• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非小细胞肺癌模型的跨尺度敏感性分析:将分子信号特性与细胞行为联系起来。

Cross-scale sensitivity analysis of a non-small cell lung cancer model: linking molecular signaling properties to cellular behavior.

作者信息

Wang Zhihui, Birch Christina M, Deisboeck Thomas S

机构信息

Harvard-MIT (HST) Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, MA 02129, USA.

出版信息

Biosystems. 2008 Jun;92(3):249-58. doi: 10.1016/j.biosystems.2008.03.002. Epub 2008 Mar 21.

DOI:10.1016/j.biosystems.2008.03.002
PMID:18448237
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2430419/
Abstract

Sensitivity analysis is an effective tool for systematically identifying specific perturbations in parameters that have significant effects on the behavior of a given biosystem, at the scale investigated. In this work, using a two-dimensional, multiscale non-small cell lung cancer (NSCLC) model, we examine the effects of perturbations in system parameters which span both molecular and cellular levels, i.e. across scales of interest. This is achieved by first linking molecular and cellular activities and then assessing the influence of parameters at the molecular level on the tumor's spatio-temporal expansion rate, which serves as the output behavior at the cellular level. Overall, the algorithm operated reliably over relatively large variations of most parameters, hence confirming the robustness of the model. However, three pathway components (proteins PKC, MEK, and ERK) and eleven reaction steps were determined to be of critical importance by employing a sensitivity coefficient as an evaluation index. Each of these sensitive parameters exhibited a similar changing pattern in that a relatively larger increase or decrease in its value resulted in a lesser influence on the system's cellular performance. This study provides a novel cross-scaled approach to analyzing sensitivities of computational model parameters and proposes its application to interdisciplinary biomarker studies.

摘要

敏感性分析是一种有效的工具,用于在研究尺度上系统地识别对给定生物系统行为有显著影响的参数中的特定扰动。在这项工作中,我们使用二维多尺度非小细胞肺癌(NSCLC)模型,研究跨越分子和细胞水平(即跨感兴趣尺度)的系统参数扰动的影响。这首先通过将分子和细胞活动联系起来,然后评估分子水平参数对肿瘤时空扩展速率的影响来实现,肿瘤时空扩展速率作为细胞水平的输出行为。总体而言,该算法在大多数参数的相对较大变化范围内可靠运行,从而证实了模型的稳健性。然而,通过使用敏感性系数作为评估指标,确定了三个信号通路成分(蛋白PKC、MEK和ERK)和十一个反应步骤至关重要。这些敏感参数中的每一个都表现出相似的变化模式,即其值相对较大的增加或减少对系统的细胞性能影响较小。本研究提供了一种新颖的跨尺度方法来分析计算模型参数的敏感性,并提出了其在跨学科生物标志物研究中的应用。

相似文献

1
Cross-scale sensitivity analysis of a non-small cell lung cancer model: linking molecular signaling properties to cellular behavior.非小细胞肺癌模型的跨尺度敏感性分析:将分子信号特性与细胞行为联系起来。
Biosystems. 2008 Jun;92(3):249-58. doi: 10.1016/j.biosystems.2008.03.002. Epub 2008 Mar 21.
2
Mig-6 overcomes gefitinib resistance by inhibiting EGFR/ERK pathway in non-small cell lung cancer cell lines.Mig-6通过抑制非小细胞肺癌细胞系中的EGFR/ERK途径克服吉非替尼耐药性。
Int J Clin Exp Pathol. 2014 Sep 15;7(10):7304-11. eCollection 2014.
3
Antitumor activity of histone deacetylase inhibitors in non-small cell lung cancer cells: development of a molecular predictive model.组蛋白去乙酰化酶抑制剂在非小细胞肺癌细胞中的抗肿瘤活性:分子预测模型的建立
Mol Cancer Ther. 2008 Jul;7(7):1923-30. doi: 10.1158/1535-7163.MCT-07-2140. Epub 2008 Jul 7.
4
Inhibition of FASN suppresses the malignant biological behavior of non-small cell lung cancer cells via deregulating glucose metabolism and AKT/ERK pathway.抑制 FASN 通过调节葡萄糖代谢和 AKT/ERK 通路抑制非小细胞肺癌细胞的恶性生物学行为。
Lipids Health Dis. 2019 May 24;18(1):118. doi: 10.1186/s12944-019-1058-8.
5
Overexpression of ELF3 facilitates cell growth and metastasis through PI3K/Akt and ERK signaling pathways in non-small cell lung cancer.ELF3 的过表达通过 PI3K/Akt 和 ERK 信号通路促进非小细胞肺癌细胞的生长和转移。
Int J Biochem Cell Biol. 2018 Jan;94:98-106. doi: 10.1016/j.biocel.2017.12.002. Epub 2017 Dec 5.
6
Glycogen synthase kinase 3 protein kinase activity is frequently elevated in human non-small cell lung carcinoma and supports tumour cell proliferation.糖原合酶激酶3的蛋白激酶活性在人类非小细胞肺癌中经常升高,并支持肿瘤细胞增殖。
PLoS One. 2014 Dec 8;9(12):e114725. doi: 10.1371/journal.pone.0114725. eCollection 2014.
7
MicroRNA-422a functions as a tumor suppressor in non-small cell lung cancer through SULF2-mediated TGF-β/SMAD signaling pathway.微小 RNA-422a 通过 SULF2 介导的 TGF-β/SMAD 信号通路在非小细胞肺癌中发挥肿瘤抑制作用。
Cell Cycle. 2019 Aug;18(15):1727-1744. doi: 10.1080/15384101.2019.1632135. Epub 2019 Jun 28.
8
Blockage of PAK1 alleviates the proliferation and invasion of NSCLC cells via inhibiting ERK and AKT signaling activity.PAK1 抑制可通过抑制 ERK 和 AKT 信号通路活性缓解非小细胞肺癌细胞的增殖和侵袭。
Clin Transl Oncol. 2021 Apr;23(4):892-901. doi: 10.1007/s12094-020-02486-5. Epub 2020 Sep 24.
9
[Non-small Cell Lung Cancer Cell Line PC-9 Drug-resistant Mutant Cell Line 
Establishment and Validation of Their Sensitivity to EGFR Inhibitors].[非小细胞肺癌细胞系PC-9耐药突变细胞系的建立及其对EGFR抑制剂敏感性的验证]
Zhongguo Fei Ai Za Zhi. 2024 Nov 20;27(11):815-825. doi: 10.3779/j.issn.1009-3419.2024.101.31.
10
Isoflurane Promotes Non-Small Cell Lung Cancer Malignancy by Activating the Akt-Mammalian Target of Rapamycin (mTOR) Signaling Pathway.异氟烷通过激活Akt-雷帕霉素哺乳动物靶蛋白(mTOR)信号通路促进非小细胞肺癌的恶性发展。
Med Sci Monit. 2016 Nov 29;22:4644-4650. doi: 10.12659/msm.898434.

引用本文的文献

1
The road to ERK activation: Do neurons take alternate routes?ERK 激活途径:神经元是否另辟蹊径?
Cell Signal. 2020 Apr;68:109541. doi: 10.1016/j.cellsig.2020.109541. Epub 2020 Jan 13.
2
A Multiscale Agent-Based Model of Ductal Carcinoma In Situ.基于多尺度代理的导管原位癌模型。
IEEE Trans Biomed Eng. 2020 May;67(5):1450-1461. doi: 10.1109/TBME.2019.2938485. Epub 2019 Oct 8.
3
Three-dimensional tumor growth in time-varying chemical fields: a modeling framework and theoretical study.时变化学场中的三维肿瘤生长:建模框架与理论研究。
BMC Bioinformatics. 2019 Aug 27;20(1):442. doi: 10.1186/s12859-019-2997-9.
4
Dynamic Targeting in Cancer Treatment.癌症治疗中的动态靶向
Front Physiol. 2019 Feb 14;10:96. doi: 10.3389/fphys.2019.00096. eCollection 2019.
5
Predictive Modeling of Drug Response in Non-Hodgkin's Lymphoma.非霍奇金淋巴瘤药物反应的预测模型
PLoS One. 2015 Jun 10;10(6):e0129433. doi: 10.1371/journal.pone.0129433. eCollection 2015.
6
Integrated PK-PD and agent-based modeling in oncology.肿瘤学中的整合药代动力学-药效学及基于主体的建模
J Pharmacokinet Pharmacodyn. 2015 Apr;42(2):179-89. doi: 10.1007/s10928-015-9403-7. Epub 2015 Jan 15.
7
Development of a sampling-based global sensitivity analysis workflow for multiscale computational cancer models.用于多尺度计算癌症模型的基于采样的全局敏感性分析工作流程的开发。
IET Syst Biol. 2014 Oct;8(5):191-7. doi: 10.1049/iet-syb.2013.0026.
8
Identification of crucial parameters in a mathematical multiscale model of glioblastoma growth.胶质母细胞瘤生长数学多尺度模型中关键参数的识别
Comput Math Methods Med. 2014;2014:437094. doi: 10.1155/2014/437094. Epub 2014 May 8.
9
Simulating cancer growth with multiscale agent-based modeling.使用基于多尺度智能体的建模方法模拟癌症生长。
Semin Cancer Biol. 2015 Feb;30:70-8. doi: 10.1016/j.semcancer.2014.04.001. Epub 2014 May 2.
10
Dealing with diversity in computational cancer modeling.应对计算癌症建模中的多样性问题。
Cancer Inform. 2013 May 7;12:115-24. doi: 10.4137/CIN.S11583. Print 2013.

本文引用的文献

1
Simulating non-small cell lung cancer with a multiscale agent-based model.使用基于多尺度智能体的模型模拟非小细胞肺癌。
Theor Biol Med Model. 2007 Dec 21;4:50. doi: 10.1186/1742-4682-4-50.
2
Sensitivity analysis of intracellular signaling pathway kinetics predicts targets for stem cell fate control.细胞内信号通路动力学的敏感性分析预测干细胞命运控制的靶点。
PLoS Comput Biol. 2007 Jul;3(7):e130. doi: 10.1371/journal.pcbi.0030130.
3
Protein kinase C epsilon is overexpressed in primary human non-small cell lung cancers and functionally required for proliferation of non-small cell lung cancer cells in a p21/Cip1-dependent manner.蛋白激酶Cε在原发性人类非小细胞肺癌中过表达,并且以p21/Cip1依赖的方式在非小细胞肺癌细胞增殖中发挥功能作用。
Cancer Res. 2007 Jul 1;67(13):6053-63. doi: 10.1158/0008-5472.CAN-06-4037.
4
Understanding the role of the tumour vasculature in the transport of drugs to solid cancer tumours.了解肿瘤血管系统在药物向实体癌肿瘤运输中的作用。
Cell Prolif. 2007 Jun;40(3):283-301. doi: 10.1111/j.1365-2184.2007.00436.x.
5
Decision tree modeling predicts effects of inhibiting contractility signaling on cell motility.决策树建模可预测抑制收缩信号对细胞运动的影响。
BMC Syst Biol. 2007 Jan 29;1:9. doi: 10.1186/1752-0509-1-9.
6
Cancer statistics, 2007.2007年癌症统计数据。
CA Cancer J Clin. 2007 Jan-Feb;57(1):43-66. doi: 10.3322/canjclin.57.1.43.
7
Radiation-induced leukemia at doses relevant to radiation therapy: modeling mechanisms and estimating risks.与放射治疗相关剂量下的辐射诱发白血病:建模机制与风险评估
J Natl Cancer Inst. 2006 Dec 20;98(24):1794-806. doi: 10.1093/jnci/djj497.
8
Quantitative transcriptional control of ErbB receptor signaling undergoes graded to biphasic response for cell differentiation.ErbB受体信号的定量转录控制在细胞分化过程中经历从分级到双相的反应。
J Biol Chem. 2007 Feb 9;282(6):4045-56. doi: 10.1074/jbc.M608653200. Epub 2006 Dec 1.
9
Dynamic modelling and analysis of biochemical networks: mechanism-based models and model-based experiments.生化网络的动态建模与分析:基于机制的模型与基于模型的实验
Brief Bioinform. 2006 Dec;7(4):364-74. doi: 10.1093/bib/bbl040. Epub 2006 Nov 14.
10
Molecular predictors of outcome with gefitinib in a phase III placebo-controlled study in advanced non-small-cell lung cancer.一项针对晚期非小细胞肺癌的III期安慰剂对照研究中吉非替尼治疗结果的分子预测指标
J Clin Oncol. 2006 Nov 1;24(31):5034-42. doi: 10.1200/JCO.2006.06.3958.